Smoking Cessation and Nicotine De-Addiction Products Market (Nicotine Replacement Therapy Products (Nicotine Gums, Nicotine Transdermal Patches, Nicotine Lozenges, Nicotine Sprays, Nicotine Inhalers, and Nicotine Sublingual Tablets), Drug Therapy (Zyban (bupropion) and Chantix/Champix (varenicline)), and E-cigarettes) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2023
- Rep Id : XPLREP1740
- Published On : April, 2018
- No. of Pages : 82
- Category : Retail
- Publisher : Transparency Market Research
Global Smoking Cessation and Nicotine De-addiction Products Market: Overview
The smoking cessation and nicotine de-addiction products market report is a veritable guide for its offerings. The report includes detailed insights into growth indices and development trends in the smoking cessation and nicotine de-addiction products market for the 2017-2023 forecast time frame by segmenting in terms of drug type and geography.
For the study, 2016 is considered as the base year and 2015 values have been provided for historical reference. The report provides revenues estimations in US$ Mn and volume estimations in Kilo tons for the 2017-2023 forecast period.
The executive summary section begins with an outline of definitions, notations, and conventions that are relevant to smoking cessation market. This is followed by detailed insights into large smoking cessation programs and rehabilitation programs that have been organized globally by welfare bodies. Details about different smoking cessation programs along with de-addiction products used are also provided herein.
The section continues with a discussion on vital market indicators such as demand drivers and opportunities that are likely to come to the fore in the smoking cessation and nicotine de-addiction products market. Following this, the qualitative and quantitative aspects of some other growth indicators such as investments and price trends that are likely to impact the smoking cessation and nicotine de-addiction products market have been discussed at length.
Insights into distribution and trade scenario, company market share, Porter’s five forces analysis, value chain analysis, and attractiveness analysis for key end users are some other highlights of this report.
Global Smoking Cessation and Nicotine De-addiction Products Market: Research Methodology
The report is a perfect example of combination of primary and secondary research methodologies. Analysts employed standard industry-best analytical tools and proven research methodologies in the making of the report. Using this approach analysts calculated revenue estimates and market share estimates of key product and application segments over the forecast period.
Analysts reached out to industry experts and key opinion leaders in the primary research phase via e-mail, telephonic interviews, and face-to-face interviews. Analysts interacted with industry experts on an ongoing basis to endorse data and analysis.
Secondary research sources reached out include annual reports, financial reports, company websites, investor presentations, broker reports, and SEC filings. In addition, some other secondary sources include pertinent licensed and regulatory databases, market reports, internal and external proprietary databases, news articles, trade journals, business publications, government documents, press releases, and webcasts specifically created for companies.
Following an extensive primary and secondary research phase, growth trends that are expected to come to the fore through 2024 are based on the following assumptions;
The study is limited to demand for smoking cessation and nicotine de-addiction products for key applications in key regions
- Market projections have been provided with the assumption that there would not be serious political disturbances or environmental calamities that could impact the growth of smoking cessation and nicotine de-addiction products market
- Overall revenue estimate of smoking cessation and nicotine de-addiction products market has been provided aggregating the revenue contribution of key drug types in key regions